HAEMONETICS CORP - Director's Dealing 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2021-02-04

Reporting Person: Goldstein Dan (VP, Corporate Controller)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-04	Common Stock	M	1457	$34.21	Acquired	3206	Direct
2021-02-04	Common Stock	S	1457	$135.84	Disposed	1749	Direct
2021-02-04	Common Stock	M	476	$93.52	Acquired	2225	Direct
2021-02-04	Common Stock	S	476	$135.88	Disposed	1749	Direct
2021-02-04	Common Stock	M	500	$98.025	Acquired	2249	Direct
2021-02-04	Common Stock	S	500	$135.72	Disposed	1749	Direct
2021-02-04	Common Stock	S	238	$136.26	Disposed	1511	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-04	Non-qualified Stock Option (Right to Buy)	$34.21	M	1457	Disposed	2023-10-25	Common Stock (1457)	Direct
2021-02-04	Non-qualified Stock Option (Right to Buy)	$93.52	M	476	Disposed	2025-06-11	Common Stock (476)	Direct
2021-02-04	Non-qualified Stock Option (Right to Buy)	$98.025	M	500	Disposed	2026-05-14	Common Stock (500)	Direct

F1: This number includes unvested restricted stock units previously reported.

F2: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.